MedPath

NMES for Rehab After Surgery

Not Applicable
Completed
Conditions
Surgery
Vascular Diseases
Registration Number
NCT04784962
Lead Sponsor
Imperial College London
Brief Summary

A randomised pilot study assessing the acceptability and feasibility of utilising neuromuscular stimulation devices to enhance post-operative rehabilitation and recovery after general, vascular and urological surgery procedures.

Detailed Description

Patients undergoing inpatient rehabilitation after general, vascular or urological surgery will be invited to take part in a randomised study utilising either sham or active neuromuscular stimulation devices to enhance post-operative rehabilitation and physiotherapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
103
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Safety and Acceptability of NMES as an adjunct for rehabilitationAt discharge from hospital (completion of study) - up to 28 days

Qualitiative assessment of participant satisfaction and acceptance of NMES device as an adjunct to standard rehabilitation via semi-structured interview

Secondary Outcome Measures
NameTimeMethod
Time to return to baseline mobility and independenceAt discharge from hospital (completion of study) - up to 28 days

Time in days to return to pre-operative mobility and independence

Rockwood Frailty IndexAt discharge from hospital (completion of study) - up to 28 days

Frailty index scoring tool at entry and exit of study

Standing for >1 minuteAt discharge from hospital (completion of study) - up to 28 days

Mobility Milestone

Walking >50mAt discharge from hospital (completion of study) - up to 28 days

Mobility Milestone

Generic Quality of life - EQ VASAt discharge from hospital (completion of study) - up to 28 days

Generic quality of life values at entry and exit of study utilising the EuroQol Visual Analogue Scale

6 Minute WalkAt discharge from hospital (completion of study) - up to 28 days

Distance walked in 6 minutes at entry and exit of study

Compliance with device usageAt discharge from hospital (completion of study) - up to 28 days

User compliance with NMES device as assessed with usage diary and qualitative feedback

Incremental cost-utility ratio, comparing NMES with standard careAt discharge from hospital (completion of study) - up to 28 days

Cost-effectiveness analysis

Length of stayAt discharge from hospital (completion of study) - up to 28 days

Hospital Length of stay

Time taken to achieve - Sitting for >5 minutesAt discharge from hospital (completion of study) - up to 28 days

Mobility Milestone

Hospital Resource useAt discharge from hospital (completion of study) - up to 28 days

Contacts with rehabilitation professionals during the using of NMES

Generic Quality of life - SF-36At discharge from hospital (completion of study) - up to 28 days

Generic quality of life values at entry and exit of study utilising the Short Form 36 health profile

Barthel IndexAt discharge from hospital (completion of study) - up to 28 days

Scoring tool of independence at entry and exit of study

Satisfaction with deviceAt discharge from hospital (completion of study) - up to 28 days

User satisfaction with NMES device assessed by qualitative feedback and assessment

Timed Up and GoAt discharge from hospital (completion of study) - up to 28 days

Time taken to stand and walk from sitting in a chair at entry and exit of study

Q FrailtyAt discharge from hospital (completion of study) - up to 28 days

Frailty assessment scale at entry and exit of study

Generic Quality of life - EQ-5DAt discharge from hospital (completion of study) - up to 28 days

Generic quality of life values at entry and exit of study utilising the EuroQol 5 Domain (EQ-5D) Health Metric

Functional Independence MeasureAt discharge from hospital (completion of study) - up to 28 days

Scoring tool of ability to function independently at entry and exit of study

Trial Locations

Locations (1)

Imperial College Healthcare NHS Trust

🇬🇧

London, United Kingdom

Imperial College Healthcare NHS Trust
🇬🇧London, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.